These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 144117)

  • 1. Effects of free fatty acids on fibrinolytic activity.
    Muraoka T; Okuda H
    J Biochem; 1977 Aug; 82(2):529-33. PubMed ID: 144117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of fibrinolysis by non-esterified fatty acids.
    Higazi AA; Aziza R; Samara AA; Mayer M
    Biochem J; 1994 May; 300 ( Pt 1)(Pt 1):251-5. PubMed ID: 8198542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of heparin on the proteolytic and fibrinolytic activity on plasmin(ogen) and fibrin clot lysis].
    Kudinov SA; Kolesnik LA; Makogonenko EM; Shuliakovskaia TA
    Biokhimiia; 1989 Nov; 54(11):1881-7. PubMed ID: 2534055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mafenide (Sulfamylon) inhibits plasmin fibrinolytic activity.
    Weisdorf DJ; Aldridge JH
    Thromb Haemost; 1988 Jun; 59(3):440-4. PubMed ID: 2973151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Unesterified long chain fatty acids inhibit the binding of single chain urokinase to the urokinase receptor.
    al-Roof Higazi A; Aceto JF; Kniss D; Upson R; Cohen R; Dichek DA; Cines DB
    Biochemistry; 1996 May; 35(21):6884-90. PubMed ID: 8639640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interactions of heparin and a covalently-linked antithrombin-heparin complex with components of the fibrinolytic system.
    Chander A; Atkinson HM; Stevic I; Berry LR; Kim PY; Chan AK
    Thromb Haemost; 2013 Dec; 110(6):1180-8. PubMed ID: 24048327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibrin-specific thrombolytic agents.
    Collen D
    Klin Wochenschr; 1988; 66 Suppl 12():15-23. PubMed ID: 3126344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced in vitro fibrinolytic activity of immobilized plasmin on collagen beads.
    Shankar H; Senatore F; Zuniga P; Venkataramani E
    J Biomed Mater Res; 1987 Jul; 21(7):897-912. PubMed ID: 2440893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Kinetics of fibrin lysis by plasmin: inhibition by fibrin degradation products].
    Zhitkova IuV; Aĭsina RB; Varfolomeev SD
    Bioorg Khim; 1996 Dec; 22(12):911-5. PubMed ID: 9054342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of phosphatidylserine on formation and lysis of fibrin].
    Byshevskiĭ ASh; Lapusova TM; Mukhacheva IA
    Vopr Med Khim; 1978; 24(4):510-4. PubMed ID: 150701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolysis in a lipid environment: modulation through release of free fatty acids.
    Rábai G; Váradi B; Longstaff C; Sótonyi P; Kristóf V; Timár F; Machovich R; Kolev K
    J Thromb Haemost; 2007 Jun; 5(6):1265-73. PubMed ID: 17403096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of action of fibrinolytic enzymes in vivo.
    Ambrus JL; Weber FJ; Ambrus CM
    J Med; 1979; 10(1-2):99-119. PubMed ID: 158624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Annexin II tetramer inhibits plasmin-dependent fibrinolysis.
    Choi KS; Ghuman J; Kassam G; Kang HM; Fitzpatrick SL; Waisman DM
    Biochemistry; 1998 Jan; 37(2):648-55. PubMed ID: 9425087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoglobulin G from patients with antiphospholipid syndrome impairs the fibrin dissolution with plasmin.
    Kolev K; Gombás J; Váradi B; Skopál J; Mede K; Pitlik E; Nagy Z; Machovich R
    Thromb Haemost; 2002 Mar; 87(3):502-8. PubMed ID: 11916083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen assay by means of the lysis time method.
    Berg W; Korsan-Bengtsen K; Ygge J
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):127-44. PubMed ID: 16955971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A method for determining plasmin by the rate of fibrin gel lysis].
    Popova GIu; Eremeev NL; Aĭsina RB; Kazanskaia NF
    Biull Eksp Biol Med; 1989 May; 107(5):561-4. PubMed ID: 2525408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Measurements of plasmin-alpha 2 plasmin inhibitor complex and FDP.D dimer levels in the fibrinolytic therapy of acute pulmonary thromboembolism].
    Yamasawa F; Hasegawa N; Asano K; Sayama K; Fujita H; Urano T; Aoki T; Ishizaka A; Kanazawa M; Kawashiro T
    Kokyu To Junkan; 1992 Jul; 40(7):685-90. PubMed ID: 1387724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimalarial effects of C18 fatty acids on Plasmodium falciparum in culture and on Plasmodium vinckei petteri and Plasmodium yoelii nigeriensis in vivo.
    Krugliak M; Deharo E; Shalmiev G; Sauvain M; Moretti C; Ginsburg H
    Exp Parasitol; 1995 Aug; 81(1):97-105. PubMed ID: 7628573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue plasminogen activator (tPA) inhibits plasmin degradation of fibrin. A mechanism that slows tPA-mediated fibrinolysis but does not require alpha 2-antiplasmin or leakage of intrinsic plasminogen.
    Wu JH; Diamond SL
    J Clin Invest; 1995 Jun; 95(6):2483-90. PubMed ID: 7769094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.